by The global fertility services market size is expected to be worth around US$ 25,720.9 million by 2030, according to a new report by Vision Research Reports.
The global fertility services market size was valued at US$ 20,400.61 million in 2020 and is anticipated to grow at a CAGR of 17.8% during forecast period 2021 to 2030.
Fertility Services Market (By End-use: Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes; By Service: Fresh Non-donor, Frozen Non-donor, Egg & Embryo Banking, Fresh Donor, Frozen Donor; By Procedure: IVF with ICSI, IUI, IVF without ICSI, Surrogacy, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030.
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38657
Treatments or procedures that aid in conception and the treatment of genetic and fertility abnormalities are referred to as reproductive services. Single parents, infertile couples, and members of the Lesbian, Gay, Bisexual, and Transgender (LGBT) community can use Assisted Reproductive Technology (ART) procedures and medications to start a family.
Growth Factor
Fertility services are treatments or procedures used to cure genetic and fertility issues and help with conception. These services include Assisted Reproductive Technology (ART) methods and drugs that help single parents, infertile couples, and the Lesbian, Gay, Bisexual, and Transgender (LGBT) community in planning a family.
Increase in the rate of infertility has occurred majorly due to factors such as increase in the consumption of alcohol and drugs, increased stress level, frequent smoking, obesity, and environmental factors. As per a study by the American Society for Reproductive medicines, in approximately 42% of infertile couples, the male partner is responsible for infertility and among them, approximately 86%-92% are treated with drugs or surgery. This is anticipated to drive the fertility services market growth.
Key Players
- APOLLO HOSPITALS ENTERPRISE LTD.
- CARE FERTILITY GROUP LTD.
- CAROLINAS FERTILITY INSTITUTE
- CITY FERTILITY
- FERTILITY ASSOCIATES LIMITED
- GENEA LIMITED
- MEDICOVER GROUP (MEDICOVER FERTILITY and FIRST EGG BANK)
- MONASH IVF GROUP LIMITED
- PROGYNY INC.
- VIRTUS HEALTH
Market Segmentation
- By End User
- Fertility Clinics
- Hospitals
- Surgical Centers
- Clinical Research Institutes
- By Service
- Fresh Non-donor
- Frozen Non-donor
- Egg & Embryo Banking
- Fresh Donor
- Frozen Donor
- By Procedure
- IVF with ICSI
- IUI
- IVF without ICSI
- Surrogacy
- Others
- By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Rest of Europe
- Asia-Pacific
- Japan
- India
- China
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
- North America
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38657
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Fertility Services Market, By Services
7.1. Fertility Services Market, by Services, 2021-2030
7.1.1. Fertility Clinics
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Hospitals
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Surgical Centers
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Clinical Research Institutes
7.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Fertility Services Market, By Services
8.1. Fertility Services Market, by Services, 2021-2030
8.1.1. Fresh Non-donor
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Frozen Non-donor
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Egg & Embryo Banking
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Fresh Donor
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Frozen Donor
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Fertility Services Market, By Procedure
9.1. Fertility Services Market, by Procedure, 2021-2030
9.1.1. IVF with ICSI
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. IUI
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. IVF without ICSI
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Surrogacy
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Fertility Services Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Services (2017-2030)
10.1.2. Market Revenue and Forecast, by Services (2017-2030)
10.1.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Services (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Services (2017-2030)
10.1.4.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Services (2017-2030)
10.1.5.2. Market Revenue and Forecast, by Services (2017-2030)
10.1.5.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Services (2017-2030)
10.2.2. Market Revenue and Forecast, by Services (2017-2030)
10.2.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Services (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Services (2017-2030)
10.2.4.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Services (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Services (2017-2030)
10.2.5.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Services (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Services (2017-2030)
10.2.6.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Services (2017-2030)
10.2.7.2. Market Revenue and Forecast, by Services (2017-2030)
10.2.7.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Services (2017-2030)
10.3.2. Market Revenue and Forecast, by Services (2017-2030)
10.3.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Services (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Services (2017-2030)
10.3.4.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Services (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Services (2017-2030)
10.3.5.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Services (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Services (2017-2030)
10.3.6.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Services (2017-2030)
10.3.7.2. Market Revenue and Forecast, by Services (2017-2030)
10.3.7.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Services (2017-2030)
10.4.2. Market Revenue and Forecast, by Services (2017-2030)
10.4.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Services (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Services (2017-2030)
10.4.4.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Services (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Services (2017-2030)
10.4.5.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Services (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Services (2017-2030)
10.4.6.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Services (2017-2030)
10.4.7.2. Market Revenue and Forecast, by Services (2017-2030)
10.4.7.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Services (2017-2030)
10.5.2. Market Revenue and Forecast, by Services (2017-2030)
10.5.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Services (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Services (2017-2030)
10.5.4.3. Market Revenue and Forecast, by Procedure (2017-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Services (2017-2030)
10.5.5.2. Market Revenue and Forecast, by Services (2017-2030)
10.5.5.3. Market Revenue and Forecast, by Procedure (2017-2030)
Chapter 11. Company Profiles
11.1. APOLLO HOSPITALS ENTERPRISE LTD.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. CARE FERTILITY GROUP LTD.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. CAROLINAS FERTILITY INSTITUTE
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. CITY FERTILITY
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. FERTILITY ASSOCIATES LIMITED
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. GENEA LIMITED
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. MEDICOVER GROUP (MEDICOVER FERTILITY and FIRST EGG BANK)
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. MONASH IVF GROUP LIMITED
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. PROGYNY INC.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. VIRTUS HEALTH
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38657
About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.
Contact Us:
call: +1 9197 992 333
Vision Research Report
Any Assistance, Email – sales@visionresearchreports.com
